Settlement valuation in MDL 3084 is now the central question, and it will be answered by the September 2026 bellwether pair more than by anything else on the docket. The first two bellwether verdicts — $8.5 million for the Dean plaintiff and approximately $5,000 for the North Carolina plaintiff — bracket a settlement range so wide that the matrix work cannot meaningfully begin until the next bellwethers narrow it. This article maps the settlement framework that MDL 3084 will likely adopt, the medical-lien categories that reduce plaintiff recovery, and the tax and structured-settlement considerations that shape net-to-client math.
The framework here builds on the hub overview of MDL 3084. For the underlying intake-evidence taxonomy that drives valuation, see the intake evidence checklist.
How MDL aggregate settlement typically works
Mass tort MDL settlements rarely resemble individual personal-injury settlements. Once a bellwether process establishes verdict ranges and damages typology, the defendant and the Plaintiffs' Steering Committee negotiate a global settlement framework that includes: (1) a total pool of funds, (2) a tier system that classifies plaintiffs by case attributes, (3) per-tier base awards, (4) adjustments for documented damages, (5) a common-benefit assessment to compensate MDL leadership work, and (6) lien resolution protocols.
The framework is opt-in for each plaintiff. Plaintiffs can decline the framework and continue to trial, but the trial path is materially slower and procedurally harder than the framework path. Practically, opt-out rates in mass-tort settlements run between 5% and 15%; most plaintiffs accept the framework once the math is clear.
For MDL 3084, the settlement framework will likely emerge between late 2026 and mid-2027, depending on how the September bellwethers shape the negotiating posture. The total pool size has not been credibly leaked; market analyst estimates range from $1.5 billion to $5 billion. The case count anchoring those estimates is the current ~3,400 MDL filings plus an expected 500-1,200 new filings before any settlement deadline.
The tier matrix
Aggregate settlement frameworks classify plaintiffs into tiers based on case attributes that correlate with bellwether verdict ranges. For MDL 3084, the likely tier attributes are:
- Severity of the assault. Penetrative vs non-penetrative; weapons involvement; duration; presence of additional violence.
- Documented harm. Medical treatment received, psychiatric diagnoses, documented work loss, prescription medication, ongoing therapy.
- Corroboration quality. Contemporaneous report (police, hospital, to Uber, to a confidant); ride record completeness; driver identification.
- Plaintiff testimony quality. Whether the plaintiff will testify at deposition and trial without re-traumatization concerns that materially impair the testimony.
- Defendant identification. Whether the assault was committed by the assigned Uber driver vs by someone else (impersonator, account hijacker, third party).
A typical mass-tort framework produces three to six tiers, with base awards spanning a factor of 10-50x between top and bottom tier. For MDL 3084, plausible tier base awards range from approximately $50,000 at the bottom tier (sparse corroboration, ambiguous corporate-conduct theory, limited documented damages) to $5-10 million at the top tier (penetrative assault, strong corroboration, severe documented harm, clear corporate-conduct nexus). These are estimates; actual tier awards will be set after the September bellwethers and PSC negotiation.
Within each tier, individual awards adjust for documented damages — medical specials, lost wages, future treatment cost — typically capped at a multiple of base. The tier matrix produces predictable awards once a plaintiff's case attributes are graded; the grading process itself is administered by a claims administrator under PSC oversight.
Medical liens that reduce recovery
Net-to-client recovery is gross recovery minus attorney fees minus medical liens minus the common-benefit assessment. The lien layer is the second-largest reduction after attorney fees and is often the most poorly understood by plaintiffs at intake.
Medicare liens (MSP). If the plaintiff received Medicare-covered treatment related to the assault, the Medicare Secondary Payer statute creates a federal lien on the recovery. Medicare liens must be resolved through the MSP Recovery Portal (MSPRP) or via direct negotiation with CMS's Benefits Coordination & Recovery Center. Penalties for failure to resolve before disbursement include double damages plus interest. In mass-tort MDL contexts, the PSC typically negotiates a global reduction with CMS, often resulting in 40-60% lien resolution at favorable terms.
Medicaid liens (state). Each state's Medicaid program has subrogation rights over recovery for medically related treatment. State Medicaid liens are governed by state statute and vary widely. In a federal MDL, state Medicaid lien resolution is generally handled case-by-case by the plaintiff's individual counsel, though some MDL frameworks include state-level Medicaid resolution as part of the global protocol.
ERISA liens. Self-funded employer health plans governed by ERISA generally have strong subrogation rights, controlled by the plan document language and the Supreme Court's US Airways v. McCutchen framework. ERISA liens often resist reduction more than government liens; plan documents typically include language designed to defeat common-fund and made-whole defenses. For plaintiffs whose treatment was covered by an ERISA self-funded plan, lien resolution is one of the biggest variables in net recovery.
Private health insurance subrogation. Non-ERISA private insurance plans have subrogation rights controlled by state law, which generally allows common-fund and made-whole-doctrine defenses that reduce lien amounts. Most state insurance laws give plaintiffs meaningful negotiating leverage on private subrogation claims.
Provider liens. Hospitals and individual providers in some states have statutory lien rights over recovery for unpaid treatment. These are typically resolved through standard lien-letter procedures and rarely affect MDL recovery materially unless treatment costs are unusually high.
Workers comp liens. Rare in passenger-rideshare cases, but possible if the plaintiff was a passenger during work-related travel and received workers comp benefits. Comp liens have strong statutory protections that resist reduction.
For a representative top-tier MDL 3084 case with $200,000 in medical and psychiatric treatment over five years, lien exposure could range from $40,000 (favorable Medicaid + private insurance posture) to $180,000 (ERISA self-funded plan with aggressive subrogation). Net-to-client variance from lien resolution alone can be six figures on the same gross recovery.
Trauma-specific treatment categories
Mental-health treatment is a substantial component of MDL 3084 damages, and the lien posture on psychiatric care differs from physical-medicine treatment.
Psychiatric inpatient and outpatient treatment, individual therapy, group therapy, and prescription medications related to PTSD, anxiety, and depression are all compensable damages categories. Most health-insurance plans cover behavioral-health treatment at parity with medical-surgical care under the Mental Health Parity and Addiction Equity Act. This means standard subrogation rules apply to psychiatric treatment liens.
Some sexual-assault-specific treatment — SANE exam costs, victim-compensation-fund-covered services, rape-crisis-center counseling — may have different lien postures depending on state victim-compensation statute. State victim-compensation programs sometimes assert subrogation rights against recovery; these vary by state and are worth checking early in intake.
Lien negotiation in MDL context
The MDL leadership structure substantially improves lien negotiating posture compared to single-plaintiff settlements. The PSC negotiates global reductions with CMS, with major Medicaid systems, and (less commonly) with major ERISA plans. These global reductions flow to individual plaintiffs through the settlement framework. Plaintiffs whose cases settle within the framework typically benefit from PSC-negotiated lien reductions that would be unattainable in solo settlement.
For practice: do not rely on individual plaintiff counsel to negotiate liens that the PSC is already addressing globally. The PSC's lien-resolution protocol is one of the substantive benefits of MDL participation, and plaintiffs who opt out of the framework lose access to it. Solo lien negotiation against ERISA self-funded plans is rarely as favorable as the PSC's aggregate posture.
Tax treatment of recovery
Under IRC § 104(a)(2), damages received "on account of personal physical injuries or physical sickness" are excludable from gross income. Sexual assault is treated as a personal physical injury for § 104(a)(2) purposes, and damages for the assault — including emotional-distress damages flowing from the assault — are generally tax-free.
Two exceptions to watch:
- Punitive damages are taxable regardless of whether the underlying claim is physical-injury based.
- Pre-judgment and post-judgment interest on settlement awards is taxable.
For most MDL 3084 plaintiffs, the recovery is structured to maximize the § 104(a)(2) exclusion — compensatory damages for the assault and related emotional distress, with punitive components (if any) separately allocated. Plaintiff counsel should coordinate with tax counsel before settlement signoff to confirm the allocation.
Structured settlements
For top-tier cases with high gross recovery, structured settlement annuities offer tax-deferred future income, asset protection, and Medicaid-eligibility preservation. Structured settlements are particularly relevant for plaintiffs whose damages include long-term psychiatric treatment, anticipated disability income loss, or government-benefit coordination.
The structured-settlement decision is made at the individual plaintiff level after the settlement matrix award is determined. The PSC does not impose structured settlements; plaintiff counsel can advise individually on structure vs lump-sum based on the plaintiff's circumstances.
The common-benefit assessment
MDL settlement frameworks typically include a common-benefit fund (CBF) assessment — a percentage of each plaintiff's gross recovery that compensates PSC counsel for work that benefited all MDL plaintiffs. Common-benefit assessments in major MDLs run between 4% and 12% of gross recovery, with the precise percentage set by the MDL court after PSC fee petitioning.
For an individual plaintiff, the CBF assessment is non-negotiable for plaintiffs who participate in the global framework. Opt-out plaintiffs avoid CBF but lose access to PSC discovery work product, lien-resolution protocols, and the framework's predictable valuation — generally a worse trade for most plaintiffs.
Net-to-client math
For a representative MDL 3084 case settling within a global framework at $1.5 million gross:
- Gross recovery: $1,500,000
- Less attorney fees (40% contingency): $600,000
- Less case costs (advanced by firm, repaid from recovery): $25,000
- Less common-benefit assessment (8%): $120,000
- Less medical liens (after PSC reduction, illustrative): $50,000
- Net to plaintiff: approximately $705,000
The percentage of gross that reaches the plaintiff in this illustration is approximately 47%. This is typical for mass-tort recovery; the spread between gross and net is one of the most consequential numbers that plaintiff counsel should explain at intake and again before settlement signoff. The illustration above is favorable; ERISA self-funded plan posture or low-corroboration cases produce worse net ratios.
The publisher's read
The lien layer is where solo practitioners outside MDL practice consistently leave money on the table. The PSC's global lien-resolution protocols are one of the most substantive benefits of MDL participation, and the math above assumes plaintiff counsel takes advantage of them. Solo settlement of sexual-assault claims against rideshare defendants — outside the MDL framework — produces substantially worse net ratios for the same gross recovery, primarily because of unmitigated ERISA and Medicare lien exposure.
For practice: walk every plaintiff through net-to-client math at intake, again after bellwether outcomes are known, and again before settlement signoff. The number that matters to the survivor is the net check, not the headline verdict; clarity about that math is the most important consumer-protection function a plaintiff lawyer performs in this docket.
See also: MDL 3084 Hub Overview | SOL by State | Intake Evidence Checklist | Laws Affecting PI Rideshare Cases